Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Integrated Global Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

IQVIA TECHNOLOGIES

"Harness technology for a healthier world.

EXPLORE MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety and quality.

COMPLIANCE OVERVIEW
Integrated Global Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2023

READ MORE

Webinar

"Global Consumer Health Trends 2023 Webinar Series

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • Connected Intelligence
  • AI & Machine Learning
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Genomics
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
AI & Machine Learning with a healthcare IQ.

Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
Unlock the power of genomic research.

IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
Winning the Evidence Race
Sarah Phillips, Senior Principal, Enterprise Solutions Real-World & Analytics Solutions
Jun 13, 2018
  • Blogs
  • Winning the evidence race

Given the complexity and the many unknowns of NASH, pursuing a traditional approach to evidence generation, e.g. by combining RCT data with existing literature, will not be sufficient to provide robust answers and convince key healthcare stakeholders. And while Real-World Data (RWD), in principle is uniquely suited for facilitating a deeper understanding of NASH, the existing data landscape is not yet fit-for-purpose to support such efforts. This is especially in Europe, where the absence of relevant, off-the-shelf data sets, the generally poor coding of NASH diagnoses, and inconsistent data capture across different settings of care create more barriers than solutions. 

In light of the sheer scale of this gap between stakeholder needs and available data in NASH, simply relying on one-off studies or setting up a long-term registry will be inadequate. There is also a risk that any solution will not be sustainable, given the evolving nature of evidence needs over time. 

This situation calls for an innovative and agile solution, and presents an opportunity for first movers to gain a head start by making early investments in shaping the data landscape in NASH. 

Early successes include building an algorithm to identify risk factors in NASH patients, and the development of a network approach to RWD, with the aspiration of establishing a pan-European collaboration of relevant NASH data source owners (e.g. NASH registries and liver specialist centers.) Ultimately, the future data landscape in NASH will emerge via a combination of efforts led by individual players as well as multi-stakeholder initiatives (e.g. LITMUS in Europe and NIMBLE in the US). 

Considering the lead times involved in building a novel evidence infrastructure, as well as the fierce competition in NASH, it is critical for pharmaceutical companies to make important choices now, far earlier than they would typically do, or feel comfortable with. This can also ensure competitive advantage, establishing an approach which other manufacturers cannot easily replicate. Success will ultimately require: 

  1. Understanding individual healthcare stakeholders’ specific evidence requirements, the burden of proof they are expecting (what is ‘good enough’?)
  2. Targeting investments on prioritized, consolidated evidence needs in the context of clinical development plans. 
  3. Forward thinking about how their evidence portfolio will grow and be enhanced over time, in line with the evolving needs of key stakeholders.

Ultimately, engaging a strong partner early in the development of a NASH evidence strategy is essential for pharmaceutical companies to secure a stake in shaping the RWD landscape with a purpose, to accelerate evidence generation and gain competitive advantage in the evidence race.

Contact Us